Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field...
Oxford Nanopore integrates "Remora": a tool to enable real-time, high-accuracy epigenetic insights with nanopore sequencing software MinKNOW
Oxford Nanopore delivers technology update at annual London Calling conference: bringing together years of innovation to showcase one sensing platform for all biological analyses
Oxford Nanopore's London Calling conference opens; amongst a breadth of ground-breaking research, increasing attention on human and cancer genomics
Oxford Nanopore sequencing selected to generate comprehensive insights by characterising a more complete genome using samples from the 1000 Genomes Project Oxford Nanopore technology will enable the 1000...
Anyone thinking about buying shares should know them, too.
Genomics England expands use of Oxford Nanopore sequencing in cancer Oxford Nanopore technology will be used by Genomics England to investigate and validate at increasing scale the benefits of sequencing...
Oxford Nanopore technology update: CTO Clive G Brown unveils latest sequencing chemistry with highest performance to date, Short Fragment Mode and latest methylation performance evaluations Clive G Brown,...
OXFORD, UK / ACCESSWIRE / March 24, 2022 / Oxford Nanopore announces positive evaluation of new method for rapid drug-resistant tuberculosis (DR-TB) profiling On World Tuberculosis Day, Oxford Nanopore,...
Oxford Nanopore releases Short Fragment Mode: a new tool for real-time sequencing of short fragments of DNA Today, Short Fragment Mode will be integrated into the operating software that drives nanopore...